Notes
Slide Show
Outline
1
IATROGENIC DRY EYE AND
ITS MANAGEMENT
  • Frank J. Holly, Ph.D.
  • Dry Eye Institute
  • Yantis, TX 75497


  • Spring, 2003
2
Refractive Surgery and the Dry Eye
    • The following major procedures are used  in refractive surgery:


    • Radial Keratotomy          -          RK  (still around)


    • Photoreafractive  Keratectomy  -  PRK  (still fairly common)


    • Laser–Assisted In-situ Keratomileusis     -     LASIK (most popular)


    • Laser epithelial keratomileusis      -   LASEK (gaining grounds)


    • They all can  cause dry eyes as a
    • – some times long lasting - complication
3
Surgical Complications Related to Dry Eye States
[Selected from 80 complication (after Sandy Keller)]
  • Corneal abrasions
  • Corneal necrosis
  • Corneal ulcers
  • Diffuse lamellar keratitis
  • Dry eye
  • Microcystic edema
  • Epithelial sloughing
  • Foreign body sensation
  • Contact lens intolerance
  • Keratitis (noninfectious)
  • Ocular pain (persistent)
  • Headache
  • Exp. palpebral fissure
  • Photophobia
  • Ptosis
  • Recurr. epithelial erosion
4
Poll Results of Members of
 Surgical Eyes, Inc.
  • Close to 4,000 members of  this group of patients have been sent a questionnaire. The questions were related to the post-surgical care of the most common complication of refractive surgery, the dry eye.


  •  One hundred sixty-three patients have replied and their responses are shown in the next few slides.  Most of these  (98%)  were post-lasik patients (2 RK and 1 PRK).
5
Provision of Post-Surgical Care
6
Medication/Device employed in post-surgical patients with complications
7
Other Treatments of Dry Eyes
in Post-surgical Patients
  • Contact lenses Erythromycin
  • Puncta cauterization Antiallergy medication
  • Bandage contact lenses Cyclosporin
  • Lid therapy Lid surgery
  • Nutrients Holistic approach


  • Artificial tears suggested:


    • any unpreserved drops Refresh,  Refresh  P.M.
    • TheraTears, Bion Celluvisc, GenTeal
    • Tears Naturale Moisture Tears
    • HypoTears Endura

8
Properties of the Tear Film

Characteristics:
  •    The tear film is actually a thin fluid film framed by the tear meniscus that are formed against the lid edges.


  •    The fluid layer in the tear meniscus is thick enough (>0.1 mm) so gravitational (hydraulic) flow can take place.
9
STABILITY OF THE TEAR FILM
Closed Eye
  •   In the closed eye, the whole superficial lipid layer is confined between adjacent lid edges.


  •   Under the closed lids there is a continuous aqueous layer which also includes the tear meniscus


  •        This aqueous layer provides
  •                  hydrodynamic lubrication
  •        for the lid moving over the globe.
10
FACTORS THAT INCREASE
TEAR FILM INSTABILITY
  • Local thinning of the tear film
  • Increase polarity of meibomian lipids*
  • Contamination by sebum*
  • Mucin (lacrimal surfactant) deficiency
  • Severely impaired tear secretion
  • Damaged surface epithelium


  • * caused by lid or skin inflammation (blepharitis, acne rosacea)


11
RUPTURE OF THE TEAR FILM
Dry Spot Formation
  • “Dry” eyes either have an unstable tear film or, in severe cases, the tear film is unable to form.


  • Does dry spot formation results from evaporation?  Unlikely!


  • Rupture of the tear film is most likely results from
  •  local non-wetting.
12
TEAR FILM BREAK-UP TIME
(BUT in seconds)
  • It is reasonable to assume (Dohlman, 1974) that BUT shorten than the blinking time interval could result in epitheliopathy of the cornea.


  • It is widely accepted (Lemp, 1976) that BUT < 10 sec is indicative of tear film instability.


  • When evaporation is minimized, BUT as long as 3 minutes has been observed in humans (Holly, 1985).
13
VITAL STAINING
  • Vital dyes commonly used for diagnosis stain epithelial surface abnormalities


  • 1. Sodium fluorescein stains frank epithelial defects (punctate-, defect, erosion)
  • 2. Rose-bengal stains hydrophobic spots (lipid-laden mucus, dead, dying cells)
  • 3.  Lissamine Green stains the same as Rose bengal but it is much less irritating.
  • Staining patterns are suggestive as to the cause of surface abnormalities.
14
Positive Rose Bengal Stain
15
BLINKING AND THE TEAR FILM
Does the Tear Film Re-form?
  • No!  The closing lids compress only the lipid layer.


  • The aqueous layer remain continuous and serves as a lubricant protecting the ocular surface from shear forces generated by the rapidly moving eye lid.


  • CAVEAT: increased viscosity of the lubricating layer could damage an already weakened epithelial surface layer.
16
BLINKING  (cont.)
  • The average time between two consecutive blinks ranges from 6 to 15 seconds.
  • Not all blinks are complete!
  • Incomplete blinkers may have inferior keratopathy (usually punctate staining).


  • Activity requiring staring decreases blinking frequency considerably.  Unless the tear film is highly stable it may be harmful in the long run.
17
TREATMENT MODALITIES
  • Supplementation  of aqueous tears (tear substitutes, lacrimal inserts, etc.)


  • Preservation of aqueous tears (goggles, punctal plugs, etc.)


  • Stimulation of aqueous tear secretion (secretagogues, eledoisin, cyclosporin)
18
Tear Supplementation
  • The use of tear substitutes (ophthalmic demulcents) is the mainstay of the treatment of the iatrogenic dry eye.


  • Unfortunately, it is widely believed that:


    • Enhanced viscosity is helpful
    • All eye drops are “created” the same
    • Hypotonic salt solutions are efficacious
    • Preservative-free drops are necessarily better

19
Tear Supplementation, cont.
  •  The main role of the eye drop should be to increase tear film stability


  • High viscosity interferes with lid lubrication, can injure loose epithelium


  • In the presence of leaky epithelium, colloid  rather than crystalloid  osmolality is important


  • Lack of preservative does not improve efficacy!
20
ONCOTIC PRESSURE
determined directly and expressed in mmHg
  • Colloid osmolality can only be determind by direct measurement of the oncotic pressure.


  • Such a solution can exert an osmotic effect even in the absence of a semi-permeable membrane (such as leaky epithelium)


  • Eye drops having an oncotic pressure higher than the stromal imbibition pressure and IOP are efficacious in healing damaged, leaky surface epithelium and improve epithelial adhesion to stroma.
21




Preservation of Aqueous Tears
  •      The approach to preserve existing
  •               tears can be two-fold:


  • diminish drainage through the puncta


  • diminish evaporation by goggles or ointments


22
WHAT ABOUT LIPID OINTMENTS?

Do they adversely affect tear film stability?

  • This problem has not been adequately studied.
  • Lipids used in ointments are mostly apolar and does not spread on hydrophilic surfaces.
  • The quantity applied is enormous compared to the mucus layer capacity to handle lipid contamination.
  • So, the hydrophobic  contamination may be more than the lacrimal system can handle…
  • ….resulting in blurry vision and interfering with the hydrodynamic lubrication  of the lids.
23
PUNCTAL PLUGS
to improve the tear meniscus
  • Discontinuous, even scanty or narrow (<0.10 mm) tear meniscus is indicative of insufficient tear volume


  • The placement of punctum plugs or sealing of the puncta may ameliorate the condition.


  • Punctal plugs are not a panacea, however.  In case of epiphora they should be removed.


  • All the four puncta should only be plugged in desperate cases.
24
 
Stimulation of Tear Secretion
  • Such drugs have been used in Europe for decades.


  • Most intriguing is eledoisin prepared from the salivary glands of the mediterranean octopus.


  • Cyclosporin-containig drops (Restasis) will soon be avavilable in the U.S.A from Allergan.
25
EFFICACIOUS ARTIFICIAL TEARS
  • The following properties/components have found to be important to ensure efficacy:


    • Achieve complete wetting of hydrophobic surfaces

    • Elevated oncotic pressure

    • Nutrients and antioxidants such as
  •                       retinoids and cyanocobalamine
26
AQUEOUS PHARMA EYE DROPS
  • A: Dwelle®, B: Dakrina®, C: REDKOTE™; D: FRESHKOTE ™


  • All four have complete wetting ability
  • Three have high oncotic pressure (except REDKOTE™)
  • Dakrina also contains vitamin A
  • REDKOTE™ also contains cyanocobalamine
  • FRESHKOTE™ also contains lipids


  • Available only through a compounding pharmacy
27
THE IATROGENIC DRY EYE
  • At least temporary dry eyes are diagnosed in about 50% of patients after refractive surgery
  • Surgery aggravates existing dry eye condition
  • Poor contact lens tolerance is a red flag for pre-lasik
  • Cosmetic surgery of the eye lid – ditto
  • Autoimmune disease in patient history - ditto
  • Certain medications: beta blockers, accutane, psychotropic drugs, antihistamine, antifungal, etc.
28
SURGICAL EYES FOUNDATION, DRY  EYE INSTITUTE&AQUEOUS PHARMA
  • joined forces and used various combinations of Aqueous Pharma eye drops to find out whether higher efficacy can be demonstrated in iatrogenic eyes as well as it could in traditional dry eye patients.


  • Volunteers were asked to keep a diary or report regularly by e-mail to the Dry Eye Institute.  Many of the patients were regularly checked by their physicians or optometrists for the condition of their surface epithelium in the eye.
29
Rational Approach to Post-lasik
Dry Eye Management
  • Eliminate the use of lipid ointment
  • Eliminate the use hypertonic salt solution
  • Employ collyrium that contains wetting polymers
  •  (A, B, C, or D)
  • Employ collyrium w/ high colloidal osmotic pressure (A, B, or D)
  • Employ collyrium  that contains bioavailable vitamin A  (B)
  • Employ collyrium with cyanocobalamine. (C)
  • Employ collyrium with phospholipids (D)


  •  A=DwelleÒ, B=DakrinaÒ, C=REDKOTE™, D=FRESHKOTE™
30
Results obtained with Surgical Foundation  Members
  • 76% participants reported:


      •  Diminished discomfort
      •  Better visual acuity
      •  Improved epithelial integrity
      •  Sharply increased incidence of epithelial erosion


      • Similar observations were made at one of the TLC by the optometrist in charge of post-lasik care.
31
Efficacy of Aqueous Pharma Drops
in Post-Lasik Patients (n =48)
32
Management of Iatrogenic Dry Eyes
Diagnostic Methods
  • Conduct the following tests:
  •         Thorough slit-lamp examination
      • Fluorescein staining (viewed with cobalt blue filter)
      • Tear film break-up time in seconds
      • Tear meniscus width and continuity
      • Corneal sensitivity
      • Lacrimation rate ability (Schirmer)  mm/5 min
      • Rose bengal (lissamine green) staining
      • Goblet cell density (by impression cytology)
      • Lid-examination (lipid interference patter)
33
Management of Iatrogenic Dry Eyes
Treatment Modalities
  • Supplementation of aqueous tears with
    • REDKOTE™ (increase BUT, heal surface)
    • DwelleÒ (increase BUT, impact eoithelium
    • DakrinaÒ (increase BUT, improve mucin deficiency)
    • FRESHKOTE™ (as before plus improve lipid abnromality)


  • Preservation of aqueous tears with
    • Goggles, transparent patches
    • Punctal plugs (start with two)
    • Avoid ointments and hypertonic preparations


    • Stimulation of tear secretion with
    • secretagogues, eledoisin, pilocarpine, cyclosporin


34
AND DO NOT FORGET TO KEEP REMINDING YOUR PATIENTS:
  • BLINK FREQUENTLY AND COMPLETELY!


  • Thank you!